Search
Lyell Immunopharma Inc
LYELAdd to Watchlist
12.740USD
+0.220+1.76%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
245.81MMarket Cap
LossP/E TTM
Lyell Immunopharma Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Lyell Immunopharma Inc is 7.19, ranking 252 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.94, which is -98.59% below the recent high of -0.01 and -470.94% above the recent low of -5.34.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
